Stress Granules in the Post-transcriptional Regulation of Immune Cells.

RNA-binding proteins (RBP) immune cells integrated stress response (ISR) mRNA mTOR post-transcriptional regulation stress granules (SG) translation

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2020
Historique:
received: 29 09 2020
accepted: 07 12 2020
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 2 2 2021
Statut: epublish

Résumé

Immune cell activation triggers transcriptional and translational programs eliciting cellular processes, such as differentiation or proliferation, essential for an efficient immune response. These dynamic processes require an intricate orchestration of regulatory mechanisms to control the precise spatiotemporal expression of proteins. Post-transcriptional regulation ensures the control of messenger RNA metabolism and appropriate translation. Among these post-transcriptional regulatory mechanisms, stress granules participate in the control of protein synthesis. Stress granules are ribonucleoprotein complexes that form upon stress, typically under control of the integrated stress response. Such structures assemble upon stimulation of immune cells where they control selective translational programs ensuring the establishment of accurate effector functions. In this review, we summarize the current knowledge about post-transcriptional regulation in immune cells and highlight the role of stress sensors and stress granules in such regulation.

Identifiants

pubmed: 33520991
doi: 10.3389/fcell.2020.611185
pmc: PMC7841200
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

611185

Informations de copyright

Copyright © 2021 Curdy, Lanvin, Cadot, Laurent, Fournié and Franchini.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Mol Cell Biol. 1989 Apr;9(4):1576-86
pubmed: 2725516
J Immunol. 2010 Nov 1;185(9):5198-204
pubmed: 20889542
Nat Chem Biol. 2009 Dec;5(12):896-903
pubmed: 19801993
J Cell Biol. 2016 Nov 7;215(3):313-323
pubmed: 27821493
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12055-60
pubmed: 19567830
Cell. 2002 Jan 25;108(2):221-32
pubmed: 11832212
Cell Rep. 2016 Nov 22;17(9):2247-2258
pubmed: 27880901
Immunity. 2016 May 17;44(5):1034-51
pubmed: 27192568
Cell Rep. 2019 Jan 2;26(1):94-107.e7
pubmed: 30605689
Nat Rev Mol Cell Biol. 2009 May;10(5):307-18
pubmed: 19339977
Trends Cell Biol. 2019 Oct;29(10):777-790
pubmed: 31378317
Nat Rev Genet. 2020 Oct;21(10):630-644
pubmed: 32709985
Nat Immunol. 2006 Jun;7(6):644-51
pubmed: 16680145
Nat Immunol. 2016 Jan;17(1):104-12
pubmed: 26551880
Nat Rev Immunol. 2020 Jan;20(1):55-70
pubmed: 31406325
Arthritis Rheum. 2001 Dec;44(12):2879-87
pubmed: 11762949
Immunity. 2005 May;22(5):633-42
pubmed: 15894280
J Biol Chem. 1996 Oct 4;271(40):24995-5002
pubmed: 8798781
Br J Pharmacol. 2019 Dec;176(23):4421-4433
pubmed: 31301065
Genes Dev. 1999 Dec 15;13(24):3280-93
pubmed: 10617576
Science. 2020 Apr 24;368(6489):
pubmed: 32327570
Nat Rev Immunol. 2017 Oct;17(10):647-660
pubmed: 28669985
Cell Rep. 2020 Sep 15;32(11):108154
pubmed: 32937139
J Cell Biol. 2004 Oct 11;167(1):27-33
pubmed: 15479734
Mol Cell. 2003 Mar;11(3):619-33
pubmed: 12667446
Nat Commun. 2017 Sep 13;8(1):530
pubmed: 28904350
EMBO Rep. 2016 Oct;17(10):1374-1395
pubmed: 27629041
Trends Biochem Sci. 2017 May;42(5):369-382
pubmed: 28268044
Mol Cell. 2007 Mar 9;25(5):765-78
pubmed: 17349961
Cell. 2018 Jan 25;172(3):590-604.e13
pubmed: 29373831
Annu Rev Genet. 2017 Nov 27;51:171-194
pubmed: 28853924
Nat Immunol. 2020 Aug;21(8):927-937
pubmed: 32632289
Immunity. 2013 Apr 18;38(4):655-68
pubmed: 23583643
J Immunol. 2019 Jan 15;202(2):579-590
pubmed: 30530594
Mol Cell. 2000 Nov;6(5):1099-108
pubmed: 11106749
Sci Rep. 2016 Sep 16;6:32886
pubmed: 27633668
Cell. 1992 Feb 7;68(3):585-96
pubmed: 1739968
Cell Rep. 2018 May 8;23(6):1754-1766
pubmed: 29742431
Science. 2014 Jan 17;343(6168):313-317
pubmed: 24310610
Nature. 2007 Nov 8;450(7167):299-303
pubmed: 18172933
Annu Rev Immunol. 2015;33:563-606
pubmed: 25665078
Trends Cell Biol. 2016 Mar;26(3):227-237
pubmed: 26597575
Mol Biosyst. 2009 Dec;5(12):1512-26
pubmed: 20023718
Cell Rep. 2017 Jul 5;20(1):188-200
pubmed: 28683312
Immunol Rev. 2013 May;253(1):253-72
pubmed: 23550651
Mol Biol Cell. 2002 Jan;13(1):195-210
pubmed: 11809833
Nat Rev Mol Cell Biol. 2018 Mar;19(3):158-174
pubmed: 29165424
Biochem J. 1993 Jan 1;289 ( Pt 1):71-9
pubmed: 8424774
Blood. 2007 Feb 15;109(4):1568-73
pubmed: 17023580
EMBO J. 2000 Aug 1;19(15):4154-63
pubmed: 10921895
PLoS Biol. 2018 Apr 5;16(4):e2005317
pubmed: 29621237
Cell Metab. 2018 Dec 4;28(6):895-906.e5
pubmed: 30197303
Biochem Biophys Res Commun. 2012 Jul 13;423(4):763-9
pubmed: 22705549
Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7729-33
pubmed: 1679235
Nat Immunol. 2017 Sep;18(9):1046-1057
pubmed: 28714979
Nat Commun. 2014 Nov 21;5:5465
pubmed: 25413384
PLoS Genet. 2013 May;9(5):e1003494
pubmed: 23658533
Epigenomics. 2014;6(4):427-43
pubmed: 25333851
Science. 2020 Mar 13;367(6483):1255-1260
pubmed: 32165587
Nature. 1999 Jan 21;397(6716):271-4
pubmed: 9930704
Nat Immunol. 2010 Aug;11(8):725-33
pubmed: 20639877
Immunity. 2017 Mar 21;46(3):488-503
pubmed: 28285833
Mol Cell. 2001 Jun;7(6):1165-76
pubmed: 11430820
FEBS J. 2010 May;277(9):2109-27
pubmed: 20412057
Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6117-E6126
pubmed: 28696283
Nat Immunol. 2019 Nov;20(11):1542-1554
pubmed: 31591570
Nature. 2011 May 19;473(7347):337-42
pubmed: 21593866
Trends Cell Biol. 2016 Sep;26(9):668-679
pubmed: 27289443
Nucleic Acids Res. 2012 Sep;40(16):8099-110
pubmed: 22718973
Science. 2018 Mar 23;359(6382):1350-1355
pubmed: 29567705
Eur J Immunol. 2019 Feb;49(2):277-289
pubmed: 30578631
Mol Cell. 2018 Dec 6;72(5):862-874.e5
pubmed: 30318442
Science. 2009 Jun 5;324(5932):1334-8
pubmed: 19498172
Nat Commun. 2018 Jun 11;9(1):2268
pubmed: 29891946
Nature. 2016 Mar 24;531(7595):523-527
pubmed: 26982722
Science. 2008 Jun 20;320(5883):1643-7
pubmed: 18566288
Mol Cell. 2005 Sep 16;19(6):777-89
pubmed: 16168373

Auteurs

Nicolas Curdy (N)

Cancer Research Center of Toulouse (CRCT), INSERM UMR 1037, CNRS ERL 5294, Toulouse, France.
Université Toulouse III Paul Sabatier, Toulouse, France.
Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

Olivia Lanvin (O)

Cancer Research Center of Toulouse (CRCT), INSERM UMR 1037, CNRS ERL 5294, Toulouse, France.
Université Toulouse III Paul Sabatier, Toulouse, France.
Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

Sarah Cadot (S)

Cancer Research Center of Toulouse (CRCT), INSERM UMR 1037, CNRS ERL 5294, Toulouse, France.
Université Toulouse III Paul Sabatier, Toulouse, France.
Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

Camille Laurent (C)

Cancer Research Center of Toulouse (CRCT), INSERM UMR 1037, CNRS ERL 5294, Toulouse, France.
Université Toulouse III Paul Sabatier, Toulouse, France.
Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Département de Pathologie, Centre Hospitalier Universitaire (CHU) de Toulouse, Toulouse, France.

Jean-Jacques Fournié (JJ)

Cancer Research Center of Toulouse (CRCT), INSERM UMR 1037, CNRS ERL 5294, Toulouse, France.
Université Toulouse III Paul Sabatier, Toulouse, France.
Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

Don-Marc Franchini (DM)

Cancer Research Center of Toulouse (CRCT), INSERM UMR 1037, CNRS ERL 5294, Toulouse, France.
Université Toulouse III Paul Sabatier, Toulouse, France.
Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.

Classifications MeSH